CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 35 enrolled
Drug / intervention
radiationradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00855803
NCT00855803Phase 2Completed
CompareCT.gov

Phase II Study of Stereotactic Body Radiation Therapy and Vertebroplasty for Localized Spinal Metastasis (SBRT Spine)

University of Texas Southwestern Medical Center·interventional·Posted Mar 4, 2009·Updated Mar 16, 2022

In Brief

A Phase 2 clinical trial evaluating radiation for Metastatic Cancer and 2 related conditions. Completed, enrolled 35 participants across 1 site.

Detailed Summary

RATIONALE: Stereotactic body radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue. Vertebroplasty may help prevent fractures and spinal cord compression caused by spinal metastasis. Giving stereotactic body radiation therapy together with vertebroplasty may help lessen pain and improve quality of life of patients with spinal metastasis. PURPOSE: This phase II trial is studying how well giving stereotactic body radiation therapy together with vertebroplasty works in treating patients with localized spinal metastasis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMetastatic Cancer, Pain, Unspecified Adult Solid Tumor, Protocol Specific
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 4, 2009
Enrollment StartFeb 1, 2009
Primary CompletionJan 20, 2021
TodayJul 2, 2026
Enrollment to primary: 12.0 yearsPosted 17.3 years ago

Interventions

radiationradiation

Given in 1 or 5 fractions